Mabpharm Limited
Status: Publicly traded
Direct answer
Mabpharm Limited is publicly traded on HKSE under the ticker 2181.HK.
Mabpharm Limited is a Chinese biopharmaceutical firm dedicated to the research, development, and manufacturing of innovative and biosimilar medications. Its therapeutic focus areas include allergic conditions, various cancers, and autoimmune disorders. The company boasts a robust pipeline, with several key products currently in advanced Phase III clinical trials. These include CMAB007, a recombinant humanized...
Can you invest in Mabpharm Limited?
Yes. Mabpharm Limited trades publicly on HKSE as 2181.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mabpharm Limited
Detailed equity research is provided by MarketSnap.